FRANKLIN, Tenn. / Apr 09, 2025 / Business Wire / Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its first quarter 2025 conference call.
The Company will issue a press release announcing its results on Wednesday, April 23, 2025, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Thursday, April 24, 2025. During this call, Community Health Systems will review the Company’s financial and operating results for the first quarter ended March 31, 2025.
A live webcast of the conference call will be available online at https://www.chs.net/investor-relations/investor-tools/webcasts/. An online replay will follow shortly after the call and continue for approximately 30 days.
You can join the live call by dialing 1-833-630-1961 (domestic) or 1-412-317-1842 (international). Once connected, request to be joined into the Community Health Systems, Inc. call. A telephonic replay of the conference call will be available through May 1, 2025, by dialing 1-877-344-7529 and entering the confirmation number, 8502644.
About Community Health Systems, Inc.
Community Health Systems, Inc. is one of the nation’s largest healthcare companies. The Company’s affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. The Company’s subsidiaries own or lease 72 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol “CYH.” The Company’s headquarters are located in Franklin, Tennessee, a suburb south of Nashville. More information about the Company can be found on its website at www.chs.net.
Last Trade: | US$2.97 |
Daily Change: | 0.06 2.06 |
Daily Volume: | 394,370 |
Market Cap: | US$416.160M |
July 22, 2025 February 18, 2025 |
ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load